LRMR icon

Larimar Therapeutics
LRMR

Overview Fund Activity

94 hedge funds and large institutions have $153M invested in Larimar Therapeutics in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 10 closing their positions.

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
2.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
35
Reduced
30
Closed
10
Calls
$5K
Puts
$34K
Net Calls
-$29K
Net Calls Change
+$90K

Top Buyers

1
AVA
1
Atlas Venture Advisors
Massachusetts
$17.4M
2
6CM
2
683 Capital Management
New York
$6.93M
3
BlackRock
3
BlackRock
New York
$12.9M
4
GPP
4
Great Point Partners
Connecticut
$17.8M
5
Morgan Stanley
5
Morgan Stanley
New York
$1.21M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$4.31M
2
Millennium Management
2
Millennium Management
New York
$386K
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$2.71M
4
KC
4
Kepos Capital
New York
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$11.5M
Name Market Value Shares Shares
Change 		Shares
Change %
DWA
101
Dorsey Wright & Associates
California
– – -1,662 Closed
QI
102
QS Investors
New York
– – -1,104 Closed
Russell Investments Group
103
Russell Investments Group
United Kingdom
– – -500 Closed
CG
104
Cutler Group
California
$0 100 -100 -50%
CFGS
105
Concourse Financial Group Securities
Alabama
– – – –
Susquehanna International Group
106
Susquehanna International Group
Pennsylvania
– – – –
1 2 3 4
5